Working to Eradicate Gynecologic Cancers

439 - Poster Session B
Predicting everolimus/letrozole treatment efficacy in patients with advanced or recurrent endometrial cancer: a biomarker study

Sunday, March 23, 2014: 4:00 PM
West Exhibit Hall (Tampa Convention Center)
Y. Jiang1, B. M. Slomovitz2, Q. Zhang3, Y. Amin1, R. Broaddus3, R. L. Coleman3 and K. H. Lu3
1Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2Women's Cancer Center, Carol G Simon Cancer Center, Morristown, NJ, 3The University of Texas MD Anderson Cancer Center, Houston, TX
 
See more of: Poster Session B
See more of: Poster Session
<< Previous Presentation | Next Presentation >>